Literature DB >> 8523188

IgA nephropathy: long-term prognosis for pediatric patients.

R J Wyatt1, S B Kritchevsky, S Y Woodford, P M Miller, S Roy, N H Holland, E Jackson, N A Bishof.   

Abstract

OBJECTIVE: The determination of the ultimate prognosis for patients with IgA nephropathy diagnosed in childhood requires long-term follow-up of identified patients. The purpose of this study was to obtain such follow-up for patients from two centers where the disease has been diagnosed for more than 20 years.
METHODS: Clinical data at the apparent onset of symptoms and renal histologic data were obtained for 103 patients in whom IgA nephropathy was diagnosed before age 18 years. Clinical status at last follow-up was obtained from office records or from direct contact with the patient. Predicted kidney survival was determined by the Kaplan-Meier method. Follow-up of more than 10 years from the time of biopsy was available for 40 of the patients.
RESULTS: Fourteen of the patients have progressed to end-stage renal disease; three others have progressive chronic renal insufficiency as defined by an estimated creatinine clearance of less than 50 ml/min per 1.73 m2. Severity of the renal histologic findings and the degree of proteinuria at the time of biopsy were associated with poor outcome. For all patients, predicted kidney survival from the time of apparent onset was 94% at 5 years, 87% at 10 years, 82% at 15 years, and 70% at 20 years. Age at clinical onset and gender were not associated with poor outcome, but black race and severity of renal histologic findings were.
CONCLUSION: With follow-up into adulthood, the outcome for pediatric patients with IgA nephropathy appears to be as serious as that reported in adult patients. Follow-up of a pediatric patient with persistent clinical findings should be maintained after the patient's care is transferred to a physician caring for adults.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8523188     DOI: 10.1016/s0022-3476(95)70027-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  31 in total

1.  Renal survival in pediatric patients with IgA nephropathy.

Authors:  M Colleen Hastings; Noel M Delos Santos; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2006-09-21       Impact factor: 3.714

Review 2.  Immunoglobulin A nephropathy: a pathophysiology view.

Authors:  Rafaela Cabral Gonçalves Fabiano; Sérgio Veloso Brant Pinheiro; Ana Cristina Simões E Silva
Journal:  Inflamm Res       Date:  2016-06-28       Impact factor: 4.575

3.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

4.  DEFA gene variants associated with IgA nephropathy in a Chinese population.

Authors:  Y Y Qi; X J Zhou; F J Cheng; P Hou; L Zhu; S F Shi; L J Liu; J C Lv; H Zhang
Journal:  Genes Immun       Date:  2015-02-12       Impact factor: 2.676

5.  Primary IgA nephropathy in children: association of clinical and pathological findings with prognosis.

Authors:  F Genel; S Arslanoğlu; B Durmaz; M Bak
Journal:  Indian J Pediatr       Date:  2001-05       Impact factor: 1.967

6.  Long-term outcome 19 years after childhood IgA nephritis: a retrospective cohort study.

Authors:  Jaana Ronkainen; Marja Ala-Houhala; Helena Autio-Harmainen; Timo Jahnukainen; Olli Koskimies; Jussi Merenmies; Jukka Mustonen; Timo Ormälä; Juha Turtinen; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2006-07-13       Impact factor: 3.714

Review 7.  Steroid therapy in children with IgA nephropathy.

Authors:  Alexandra Cambier; Olivia Boyer; Georges Deschenes; James Gleeson; Anne Couderc; Julien Hogan; Thomas Robert
Journal:  Pediatr Nephrol       Date:  2019-02-18       Impact factor: 3.714

8.  Incidence of pediatric IgA nephropathy.

Authors:  Yasushi Utsunomiya; Takayuki Koda; Tadashi Kado; Sinichi Okada; Atsushi Hayashi; Susumu Kanzaki; Tsunakiyo Kasagi; Hiroshi Hayashibara; Teruo Okasora
Journal:  Pediatr Nephrol       Date:  2003-04-29       Impact factor: 3.714

9.  Impact of the -675 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene on childhood IgA nephropathy.

Authors:  Su-Ryun Han; Cheon-Jong Kim; Byung-Cheol Lee
Journal:  Exp Ther Med       Date:  2012-01-30       Impact factor: 2.447

Review 10.  Idiopathic immunoglobulin A nephropathy in children and adolescents.

Authors:  Ronald J Hogg
Journal:  Pediatr Nephrol       Date:  2009-02-05       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.